# US 2015/0174140 A1 · Method for on-demand contraception

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0174140 A1
- Document ID: US20150174140A1
- Status: Published application
- Kind: A1
- Application number: 14/635,107
- Filed: 2015-03-02
- Published: 2015-06-25
- Earliest claimed: 2009-04-14
- Assignees: Laboratoire Hra-Pharma; The United States of America, as represented by the Secretary, Department of Health and Human Serv
- Applicants: Laboratoire Hra Pharma; The United States of America, as represented by the Secretary, Department of Health and Human Serv
- Inventors: Andre Ulmann; Erin Gainer; Henri Camille Mathe; Diana Blithe; Lynnette Nieman
- Web page: https://patentgrep.com/patent/US20150174140A1

## CPC

- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 9/0036: {Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/20: Pills, tablets, {discs, rods (A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095)}
- A61K 9/2004: {Excipients; Inactive ingredients}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 31/56: Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K 31/57: substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61P 15/18: Feminine contraceptives
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-11b-(4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.

## Claims

### Claim 1

A method for contraception comprising the step of administering about 30 mg of ulipristal acetate to a woman within 120 hours after an unprotected intercourse.

### Claim 2 (depends on 1)

The method of claim 1, wherein the administration is oral.

### Claim 3 (depends on 1)

The method of claim 1 wherein ulipristal acetate is administered within 72 hours after intercourse.

### Claim 4 (depends on 1)

The method of claim 1, wherein ulipristal acetate is administered as an oral solid dosage form.

### Claim 5 (depends on 4)

The method of claim 4, wherein the oral solid dosage form is a tablet.

### Claim 6 (depends on 1)

The method of claim 1, wherein ulipristal acetate is administered as an immediate-release formulation.
